NCM
Nantahala Capital Management’s Soleno Therapeutics SLNO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.9M | Sell |
1,001,350
-755,673
| -43% | -$63.3M | 3.29% | 1 |
|
|
2025
Q1 | $126M | Sell |
1,757,023
-2,171,943
| -55% | -$155M | 4.99% | 1 |
|
|
2024
Q4 | $177M | Buy |
3,928,966
+658,518
| +20% | +$29.6M | 7.58% | 1 |
|
|
2024
Q3 | $165M | Buy |
3,270,448
+188,341
| +6% | +$9.51M | 8.35% | 1 |
|
|
2024
Q2 | $126M | Buy |
3,082,107
+671,728
| +28% | +$27.4M | 7.35% | 1 |
|
|
2024
Q1 | $103M | Sell |
2,410,379
-445,972
| -16% | -$19.1M | 5.89% | 1 |
|
|
2023
Q4 | $115M | Buy |
2,856,351
+2,463,947
| +628% | +$99.2M | 6.87% | 1 |
|
|
2023
Q3 | $11.6M | Sell |
392,404
-257,437
| -40% | -$7.6M | 0.99% | 16 |
|
|
2023
Q2 | $2.79M | Sell |
649,841
-49,523
| -7% | -$212K | 0.27% | 59 |
|
|
2023
Q1 | $1.5M | Buy |
699,364
+95,185
| +16% | +$204K | 0.11% | 71 |
|
|
2022
Q4 | $1.2M | Hold |
604,179
| – | – | 0.08% | 71 |
|
|
2022
Q3 | $1.01M | Sell |
604,179
-8,832,333
| -94% | -$14.8M | 0.07% | 74 |
|
|
2022
Q2 | $1.68M | Hold |
9,436,512
| – | – | 0.08% | 69 |
|
|
2022
Q1 | $2.1M | Sell |
9,436,512
-328,617
| -3% | -$73.3K | 0.09% | 72 |
|
|
2021
Q4 | $4M | Hold |
9,765,129
| – | – | 0.14% | 63 |
|
|
2021
Q3 | $9.03M | Hold |
9,765,129
| – | – | 0.28% | 50 |
|
|
2021
Q2 | $11.1M | Buy |
9,765,129
+1,948,400
| +25% | +$2.22M | 0.32% | 48 |
|
|
2021
Q1 | $9.85M | Sell |
7,816,729
-54,627
| -0.7% | -$68.8K | 0.29% | 52 |
|
|
2020
Q4 | $15.2M | Buy |
7,871,356
+444,988
| +6% | +$859K | 0.47% | 42 |
|
|
2020
Q3 | $18.6M | Hold |
7,426,368
| – | – | 0.57% | 30 |
|
|
2020
Q2 | $16.5M | Buy |
7,426,368
+3,148,445
| +74% | +$6.99M | 0.5% | 34 |
|
|
2020
Q1 | $10.2M | Hold |
4,277,923
| – | – | 0.38% | 33 |
|
|
2019
Q4 | $12.6M | Buy |
+4,277,923
| New | +$12.6M | 0.39% | 33 |
|